Emerging technologies for improving phytochemical bioavailability: Benefits and risks

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 6, 2011, Pages 915-919

  Gurley, B J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILOBALIDE; CATECHIN; CURCUMIN; CYTOCHROME P450 INHIBITOR; EPIGALLOCATECHIN GALLATE; FLAVONOLIGNAN; GINKGOLIDE; GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; GOMISIN; HYDRASTINE; LIPOSOME; NANOSPHERE; PIPERINE; PLANT EXTRACT; PROANTHOCYANIDIN; QUERCETIN; SILIBININ; SILYMARIN; SOLID LIPID NANOPARTICLE;

ARTICLE; AUTOTROPH; BLACK PEPPER; COMPLEX FORMATION; CURCUMA LONGA; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG MANUFACTURE; ENVIRONMENTAL STRESS; GINKGO BILOBA; GRAPE; HERB DRUG INTERACTION; HERBIVORE; HETEROTROPH; HUMAN; HYDRASTIS; HYDROPHOBICITY; LIPOPHILICITY; LIPOSOMAL DELIVERY; MICROEMULSION; MOLECULAR WEIGHT; PHYLOGENY; PHYTOCHEMISTRY; PLANT CELL; PLANT GROWTH; PLANT REPRODUCTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHELF LIFE; SILYBUM MARIANUM; TEA; XENOBIOTIC METABOLISM;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOTECHNOLOGY; DIETARY SUPPLEMENTS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 79956312428     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.51     Document Type: Article

References (32)

1. Bailey, R.L. et al. Dietary supplement use in the United States, 2003-2006. J. Nutr. 141, 261-266 (2011).
2. Biesalski, H.K. et al. Bioactive compounds: safety and efcacy. Nutrition 25, 1206-1211 (2009).
3. Yeung, K.S., Gubili, J. & Cassileth, B. Evidence-based botanical research: applications and challenges. Hematol. Oncol. Clin. North Am. 22, 661-70, Viii (2008). (Pubitemid 351973320)
4. Gonzalez, F.J. & Nebert, D.W. Evolution of the P450 gene superfamily: animal-plant "warfare," molecular drive and human genetic diferences in drug oxidation. Trends Genet. 60, 265-271 (1990).
5. Briskin, D.P. Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol. 124, 507-514 (2000).
6. Bock, K.W. Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects. Biochem. Pharmacol. 66, 691-696 (2003). (Pubitemid 37011407)
7. Paulsen, I.T. Multidrug efux pumps and resistance: regulation and evolution. Curr. Opin. Microbiol. 6, 446-451 (2003). (Pubitemid 37345408)
8. Van Breeman, R.B., Fong, H.H.S. & Farnsworth, N.R. Ensuring the safety of botanical dietary supplements. Am. J. Clin. Nutr. 87(suppl.), 509S-513S (2008). (Pubitemid 351226095)
9. Schulz, H-U, Schurer, M., Krumbiegel, G., Wachter, W., Weyhenmeyer, R. & Seidel, G. Investigation of dissolution and bioequivalence of silymarin products. Arzneim-Forsch. 45, 61-64 (1995).
10. Ajazuddin, & Saraf, S. Applications of novel drug delivery system for herbal formulations. Fitoterapia 81, 680-689 (2010).
11. Musthaba, S.M., Baboota, S., Ahmed, S., Ahuja, A. & Ali, J. Status of novel drug delivery technology for phytotherapeutics. Expert Opin. Drug Deliv. 6, 625-637 (2009).
12. El-Samaligy, M.S., Aff, N.N. & Mahmoud, E.A. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int. J. Pharm. 319, 121-129 (2006). (Pubitemid 44051811)
13. Yan-Yu, X., Yun-Mei, S., Zhi-Peng, C. & Qi-Neng, P. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int. J. Pharm. 319, 162-168 (2006).
14. Takahashi, M., Uechi, S., Takara, K., Asikin, Y. & Wada, K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J. Agric. Food Chem. 57, 9141-9146 (2009).
15. Huang, Y.B., Tsai, M.J., Wu, P.C., Tsai, Y.H., Wu, Y.H. & Fang, J.Y. Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J. Drug Target.; e-pub ahead of print 11 February 2011 (2011).
16. Ghosh, A., Mandal, A.K., Sarkar, S., Panda, S. & Das, N. Nanoencapsulation of quercetin enhances its dietary efcacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sci. 84, 75-80 (2009).
17. Kidd, P.M. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, Curcumin, Green tea, And grape seed extracts. Altern. Med. Rev. 14, 226-246 (2009).
18. Semalty, A., Semalty, M., Rawat, M.S. & Franceschi, F. Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. Fitoterapia 81, 306-314 (2010).
19. Kidd, P. & Head, K. A review of the bioavailability and clinical efcacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern. Med. Rev. 10, 193-203 (2005). (Pubitemid 41384033)
20. Mauri, P. et al. Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts. Rapid Commun. Mass Spectrom. 15, 929-934 (2001). (Pubitemid 32587181)
21. Kumar, A., Ahuja, A., Ali, J. & Baboota, S. Conundrum and therapeutic potential of curcumin in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 27, 279-312 (2010).
22. Kakkar, V., Singh, S., Singla, D. & Kaur I.P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol. Nutr. Food Res. 54, 1-9 (2010).
23. Nair, H.B., Sung, B., Yadav, V.R., Kannappan, R., Chaturvedi, M.M. & Aggarwal, B.B. Delivery of antiinfammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem. Pharmacol. 80, 1833-1843 (2010).
24. Singh, B., Bandopadhyay, S., Kapil, R., Singh, R. & Katare, O. Self-emulsifying drug delivery systems (SEDDS): formulation development, Characterization, And applications. Crit. Rev. Ther. Drug Carrier Syst. 26, 427-521 (2009).
25. Tang, J., Sun, J., Cui, F., Zhang, T., Liu, X. & He, Z. Self-emulsifying drug delivery systems for improving oral absorption of ginkgo biloba extracts. Drug Deliv. 15, 477-484 (2008).
26. Shao, B. et al. Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems. Drug Dev. Ind. Pharm. 36, 1356-1363 (2010).
27. Wu, X., Xu, J., Huang, X. & Wen, C. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev. Ind. Pharm. 37, 15-23 (2011).
28. Wu, W., Wang, Y. & Que, L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 63, 288-294 (2006). (Pubitemid 43776222)
29. Bhardwaj, R.K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S.K. & Fromm, M.F. Piperine, A major constituent of black pepper, Inhibits human P-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther. 302, 645-650 (2002). (Pubitemid 34787231)
30. Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R. & Srinivas, P.S. Infuence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64, 353-356 (1998). (Pubitemid 28234275)
31. Siddiqui, B.S., Gulzar, T., Begum, S., Afshan, F. & Sattar, F.A. Insecticidal amides from fruits of Piper nigrum Linn. Nat. Prod. Res. 19, 143-150 (2005). (Pubitemid 40185882)
32. Murray, M. Mechanisms of inhibitory and regulatory efects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation. Curr. Drug Metab. 1, 67-84 (2000).